Protective action of B1R antagonist against cerebral ischemia-reperfusion injury through suppressing miR-200c expression of Microglia-derived microvesicles
Author:
Affiliation:
1. Department of Neurology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
Funder
National Natural Science Foundation of China
Natural Science Foundation of Zhejiang Province
Zhejiang Provincial Natural Science Foundation
Publisher
Informa UK Limited
Subject
Neurology (clinical),Neurology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/01616412.2016.1275096
Reference37 articles.
1. Interaction of Recanalization, Intracerebral Hemorrhage, and Cerebral Edema After Intravenous Thrombolysis
2. Rapid endothelial cytoskeletal reorganization enables early blood–brain barrier disruption and long-term ischaemic reperfusion brain injury
3. The pro-resolving lipid mediator Maresin 1 protects against cerebral ischemia/reperfusion injury by attenuating the pro-inflammatory response
4. Chrysin Protects against Focal Cerebral Ischemia/Reperfusion Injury in Mice through Attenuation of Oxidative Stress and Inflammation
5. Contribution of the Kallikrein/Kinin System to the Mediation of ConA-Induced Inflammatory Ascites
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Ulinastatin Improves Endothelial Cells Injury, Attenuating Cardiac Ischemia/Reperfusion Injury via Suppressing Tissue kallikrein-kinin System Activation;2023-07-11
2. Ulinastatin Ameliorates Cardiac Ischemia/Reperfusion Injury via Inhibiting the tissue kallikrein-kinin system;2023-02-26
3. Ulinastatin Ameliorates Cardiac Ischemia/Reperfusion Injury via Inhibiting the tissue kallikrein-kinin system;2023-02-24
4. Whole patient knowledge modeling of COVID-19 symptomatology reveals common molecular mechanisms;Frontiers in Molecular Medicine;2023-01-04
5. Upregulation of miRNA-200c during Disease Progression in COVID-19 Patients;Journal of Clinical Medicine;2022-12-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3